Literature DB >> 30348641

Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1.

Alexander K H Weiss1,2, Andreas Naschberger3,4, Johannes R Loeffler2,5, Hubert Gstach6, Matthew W Bowler7, Max Holzknecht1,2, Elia Cappuccio1,2, Annabella Pittl1,2, Solmaz Etemad1,2, Theresia Dunzendorfer-Matt3, Klaus Scheffzek8, Klaus R Liedl9,5, Pidder Jansen-Dürr10,2.   

Abstract

Whereas enzymes in the fumarylacetoacetate hydrolase (FAH) superfamily catalyze several distinct chemical reactions, the structural basis for their multi-functionality remains elusive. As a well-studied example, human FAH domain-containing protein 1 (FAHD1) is a mitochondrial protein displaying both acylpyruvate hydrolase (ApH) and oxaloacetate decarboxylase (ODx) activity. As mitochondrial ODx, FAHD1 acts antagonistically to pyruvate carboxylase, a key metabolic enzyme. Despite its importance for mitochondrial function, very little is known about the catalytic mechanisms underlying FAHD1 enzymatic activities, and the architecture of its ligated active site is currently ill defined. We present crystallographic data of human FAHD1 that provide new insights into the structure of the catalytic center at high resolution, featuring a flexible 'lid'-like helical region which folds into a helical structure upon binding of the ODx inhibitor oxalate. The oxalate-driven structural transition results in the generation of a potential catalytic triad consisting of E33, H30 and an associated water molecule. In silico docking studies indicate that the substrate is further stabilized by a complex hydrogen-bond network, involving amino acids Q109 and K123, identified herein as potential key residues for FAHD1 catalytic activity. Mutation of amino acids H30, E33 and K123 each had discernible influence on the ApH and/or ODx activity of FAHD1, suggesting distinct catalytic mechanisms for both activities. The structural analysis presented here provides a defined structural map of the active site of FAHD1 and contributes to a better understanding of the FAH superfamily of enzymes.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  FAHD1; bifunctionality; crystallography

Mesh:

Substances:

Year:  2018        PMID: 30348641      PMCID: PMC7610682          DOI: 10.1042/BCJ20180750

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  Inhibitors of Fumarylacetoacetate Hydrolase Domain Containing Protein 1 (FAHD1).

Authors:  Alexander K H Weiss; Richard Wurzer; Patrycia Klapec; Manuel Philip Eder; Johannes R Loeffler; Susanne von Grafenstein; Stefania Monteleone; Klaus R Liedl; Pidder Jansen-Dürr; Hubert Gstach
Journal:  Molecules       Date:  2021-08-18       Impact factor: 4.411

2.  Regulation of cellular senescence by eukaryotic members of the FAH superfamily - A role in calcium homeostasis?

Authors:  Alexander K H Weiss; Eva Albertini; Max Holzknecht; Elia Cappuccio; Ilaria Dorigatti; Anna Krahbichler; Elisabeth Damisch; Hubert Gstach; Pidder Jansen-Dürr
Journal:  Mech Ageing Dev       Date:  2020-06-20       Impact factor: 5.432

3.  Expression, Purification, Crystallization, and Enzyme Assays of Fumarylacetoacetate Hydrolase Domain-Containing Proteins.

Authors:  Alexander K H Weiss; Max Holzknecht; Elia Cappuccio; Ilaria Dorigatti; Karin Kreidl; Andreas Naschberger; Bernhard Rupp; Hubert Gstach; Pidder Jansen-Dürr
Journal:  J Vis Exp       Date:  2019-06-20       Impact factor: 1.355

4.  Structural and functional comparison of fumarylacetoacetate domain containing protein 1 in human and mouse.

Authors:  Alexander K H Weiss; Andreas Naschberger; Elia Cappuccio; Christina Metzger; Lorenza Mottes; Max Holzknecht; Jill von Velsen; Matthew W Bowler; Bernhard Rupp; Pidder Jansen-Dürr
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

5.  AtFAHD1a: A New Player Influencing Seed Longevity and Dormancy in Arabidopsis?

Authors:  Davide Gerna; Erwann Arc; Max Holzknecht; Thomas Roach; Pidder Jansen-Dürr; Alexander K H Weiss; Ilse Kranner
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.